Expertise in
12
conditions

Jason G. Andrade

Vancouver, BC, CA 
Expertise in
12
conditions
Vancouver, BC, CA 

Overview

Jason Andrade practices practicing medicine in Vancouver, Canada.

Mr. Andrade is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Ectopic Heartbeat, Arrhythmias, Cardiac Ablation, and Osteotomy.

He is actively involved in clinical research, co-authoring 334 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Vancouver, BC, Canada
Other Locations
Vancouver, Canada
Montreal, QC, Canada
Kelowna, BC, Canada
Toronto, ON, Canada
Sherbrooke, Rouge Valley Centenary Hospital, Calgary, AB, St. Mary's Hospital, Hamilton, ON, St. Michael's Hospital, Ottawa, ON, Canada
Sherbrooke, Rouge Valley Centenary Hospital, Calgary, AB, St. Mary's General Hospital, Victoria, Hamilton, ON, St. Michael's Hospital, Prince Albert, SK, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation (Coast-AF) Randomized Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Enrollment Status: Terminated
Publish Date: June 15, 2025
Intervention Type: Other, Drug
Study Drug: Rivaroxaban
Study Phase: Phase 3
Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation
Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation
Enrollment Status: Completed
Publish Date: April 03, 2025
Intervention Type: Device
Study Phase: Not Applicable
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Early Aggressive Invasive Intervention for Atrial Fibrillation
Early Aggressive Invasive Intervention for Atrial Fibrillation
Enrollment Status: Unknown
Publish Date: October 10, 2022
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
Cryoballoon vs. Irrigated Radiofrequency Catheter Ablation: The Effect of Double Short vs. Standard Exposure Cryoablation Duration During Pulmonary Vein Isolation.
Cryoballoon vs. Irrigated Radiofrequency Catheter Ablation: The Effect of Double Short vs. Standard Exposure Cryoablation Duration During Pulmonary Vein Isolation.
Enrollment Status: Completed
Publish Date: May 07, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 6 Less Clinical Trials

334 Total Publications

Erratum: Author Correction to "Variation in Availability of Continuous Ambulatory Electrocardiographic Monitors Across Canadian Provinces [CJC Open. Volume 7, Issue 9, Pages 1157-1161. DOI:doi.org/10.1016/j.cjco.2025.06.005]".
Erratum: Author Correction to "Variation in Availability of Continuous Ambulatory Electrocardiographic Monitors Across Canadian Provinces [CJC Open. Volume 7, Issue 9, Pages 1157-1161. DOI:doi.org/10.1016/j.cjco.2025.06.005]".
Journal: CJC open
Published: August 18, 2026

Frequently Asked Questions about Jason G. Andrade

Is Jason G. Andrade a top-rated expert for Atrial Fibrillation?

MediFind is an objective health platform that identifies experts based on real-world data. Jason G. Andrade is classified as an Elite expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jason G. Andrade participate in research or clinical trials?

Yes. Jason G. Andrade has published 334 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Jason G. Andrade's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Andrade's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile